We are live on ! Find out more
VCM

Versant Capital Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.66%
AUM
$1.01B
AUM Growth
+$217M
Cap. Flow
+$212M
Cap. Flow %
20.87%
Top 10 Hldgs %
33.44%
Holding
2,859
New
220
Increased
1,610
Reduced
469
Closed
82

Sector Composition

Rank Sector Weight
1 Technology 17.87%
2 Financials 6.8%
3 Industrials 6.1%
4 Consumer Discretionary 4.96%
5 Healthcare 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MQ icon
2726
Marqeta
MQ
$1.66B
$465 ﹤0.01%
29
-581
-95% -$9.79K
FUN icon
2727
Cedar Fair
FUN
$1.67B
$462 ﹤0.01%
26
SHAK icon
2728
Shake Shack
SHAK
$2.87B
$442 ﹤0.01%
+5
New +$460
CYH icon
2729
Community Health Systems
CYH
$423M
$441 ﹤0.01%
150
TRNS icon
2730
Transcat
TRNS
$871M
$441 ﹤0.01%
+6
New +$422
CRVS icon
2731
Corvus Pharmaceuticals
CRVS
$1.17B
$410 ﹤0.01%
+28
New +$447
SQM icon
2732
Sociedad Química y Minera de Chile
SQM
$20.6B
$405 ﹤0.01%
+5
New +$381
ETH
2733
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.75B
$397 ﹤0.01%
20
BVN icon
2734
Compañía de Minas Buenaventura
BVN
$8.67B
$396 ﹤0.01%
+11
New +$397
CHE icon
2735
Chemed
CHE
$7.22B
$378 ﹤0.01%
1
-1
-50% -$428
HRTG icon
2736
Heritage Insurance Holdings
HRTG
$991M
$368 ﹤0.01%
+14
New +$369
EQBK icon
2737
Equity Bancshares
EQBK
$1.05B
$355 ﹤0.01%
+8
New +$364
ZUMZ icon
2738
Zumiez
ZUMZ
$339M
$355 ﹤0.01%
16
BYRN icon
2739
Byrna Technologies
BYRN
$101M
$349 ﹤0.01%
+38
New +$498
KROS icon
2740
Keros Therapeutics
KROS
$221M
$342 ﹤0.01%
+31
New +$479
ZVRA icon
2741
Zevra Therapeutics
ZVRA
$686M
$336 ﹤0.01%
+36
New +$325
CMRE icon
2742
Costamare
CMRE
$1.77B
$321 ﹤0.01%
+19
New +$315
NBBK icon
2743
NB Bancorp
NBBK
$989M
$316 ﹤0.01%
+15
New +$315
FIGR
2744
Figure Technology Solutions
FIGR
$6.33B
$306 ﹤0.01%
+9
New +$388
NAGE
2745
Niagen Bioscience
NAGE
$247M
$304 ﹤0.01%
69
-1,055
-94% -$5.7K
AMPX icon
2746
Amprius Technologies
AMPX
$1.73B
$303 ﹤0.01%
+18
New +$235
MYFW icon
2747
First Western Financial
MYFW
$306M
$295 ﹤0.01%
12
XERS icon
2748
Xeris Biopharma Holdings
XERS
$1.45B
$284 ﹤0.01%
+49
New +$325
GLOB icon
2749
Globant
GLOB
$1.61B
$277 ﹤0.01%
6
-559
-99% -$30.9K
SNAP icon
2750
Snap
SNAP
$9.01B
$253 ﹤0.01%
55
-56
-50% -$330

Similar funds

Versant Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Versant Capital Management held 2,859 positions worth $1.01B, up 27% from $797M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Versant Capital Management deployed $212M of net new capital in Q1 2026, opening 220 new positions and adding to 1,610 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $1.27M trimmed.

  • Versant Capital Management's largest Q1 2026 buy was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
  • Versant Capital Management added most to Microsoft in Q1 2026, an estimated $57.7M increase.
  • Versant Capital Management's biggest Q1 2026 reduction was VanEck Gold Miners ETF, cutting an estimated $1.27M.
  • Versant Capital Management fully exited AstraZeneca in Q1 2026, selling an estimated $1.1M.
  • Versant Capital Management's ten largest holdings make up 33% of its $1.01B portfolio in Q1 2026.
  • Versant Capital Management opened 220 new positions and closed 82 in Q1 2026.
  • Versant Capital Management's portfolio value rose 27% quarter-over-quarter to $1.01B.

Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.